• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤细胞从不孤单:肿瘤微环境中的串扰和通讯。

NK cells are never alone: crosstalk and communication in tumour microenvironments.

机构信息

The First School of Clinical Medicine, Lanzhou University, 222 Tianshui South Road, Lanzhou, 730000, China.

Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.

出版信息

Mol Cancer. 2023 Feb 16;22(1):34. doi: 10.1186/s12943-023-01737-7.

DOI:10.1186/s12943-023-01737-7
PMID:36797782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9933398/
Abstract

Immune escape is a hallmark of cancer. The dynamic and heterogeneous tumour microenvironment (TME) causes insufficient infiltration and poor efficacy of natural killer (NK) cell-based immunotherapy, which becomes a key factor triggering tumour progression. Understanding the crosstalk between NK cells and the TME provides new insights for optimising NK cell-based immunotherapy. Here, we present new advances in direct or indirect crosstalk between NK cells and 9 specialised TMEs, including immune, metabolic, innervated niche, mechanical, and microbial microenvironments, summarise TME-mediated mechanisms of NK cell function inhibition, and highlight potential targeted therapies for NK-TME crosstalk. Importantly, we discuss novel strategies to overcome the inhibitory TME and provide an attractive outlook for the future.

摘要

免疫逃逸是癌症的一个标志。动态且异质性的肿瘤微环境 (TME) 导致自然杀伤 (NK) 细胞为基础的免疫疗法的浸润不足和疗效不佳,这成为触发肿瘤进展的关键因素。了解 NK 细胞与 TME 之间的相互作用为优化 NK 细胞为基础的免疫疗法提供了新的见解。在这里,我们介绍了 NK 细胞与 9 种专门的 TME 之间直接或间接相互作用的新进展,包括免疫、代谢、神经支配的生态位、机械和微生物微环境,总结了 TME 介导的 NK 细胞功能抑制机制,并强调了针对 NK-TME 相互作用的潜在靶向治疗方法。重要的是,我们讨论了克服抑制性 TME 的新策略,并为未来提供了有吸引力的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/8643077ad440/12943_2023_1737_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/67388bf7fdc4/12943_2023_1737_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/4f89e51b3cd9/12943_2023_1737_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/f48ead9ac0cf/12943_2023_1737_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/c573e201565a/12943_2023_1737_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/8643077ad440/12943_2023_1737_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/67388bf7fdc4/12943_2023_1737_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/4f89e51b3cd9/12943_2023_1737_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/f48ead9ac0cf/12943_2023_1737_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/c573e201565a/12943_2023_1737_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52b8/9933398/8643077ad440/12943_2023_1737_Fig5_HTML.jpg

相似文献

1
NK cells are never alone: crosstalk and communication in tumour microenvironments.自然杀伤细胞从不孤单:肿瘤微环境中的串扰和通讯。
Mol Cancer. 2023 Feb 16;22(1):34. doi: 10.1186/s12943-023-01737-7.
2
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.细胞因子在肿瘤微环境中协调自然杀伤细胞与髓系细胞的相互作用:对基于自然杀伤细胞的癌症免疫治疗的意义。
Front Immunol. 2021 Jan 29;11:621225. doi: 10.3389/fimmu.2020.621225. eCollection 2020.
3
Crosstalk between macrophages and natural killer cells in the tumor microenvironment.肿瘤微环境中巨噬细胞与自然杀伤细胞的串扰。
Int Immunopharmacol. 2021 Dec;101(Pt B):108374. doi: 10.1016/j.intimp.2021.108374. Epub 2021 Nov 22.
4
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?在肿瘤微环境中释放自然杀伤细胞——下一代免疫疗法?
Front Immunol. 2020 Feb 21;11:275. doi: 10.3389/fimmu.2020.00275. eCollection 2020.
5
Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.肿瘤微环境中树突状细胞与自然杀伤细胞之间串扰的表征与调控
Front Immunol. 2021 May 14;12:670540. doi: 10.3389/fimmu.2021.670540. eCollection 2021.
6
Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.肿瘤微环境中自然杀伤细胞代谢重编程对自然杀伤细胞疗法影响的研究进展
J Transl Med. 2024 Mar 3;22(1):229. doi: 10.1186/s12967-024-05033-w.
7
Harnessing Natural Killer Cells for Lung Cancer Therapy.利用自然杀伤细胞进行肺癌治疗。
Cancer Res. 2023 Oct 13;83(20):3327-3339. doi: 10.1158/0008-5472.CAN-23-1097.
8
NK Cell Metabolism and Tumor Microenvironment.自然杀伤细胞代谢与肿瘤微环境。
Front Immunol. 2019 Sep 24;10:2278. doi: 10.3389/fimmu.2019.02278. eCollection 2019.
9
Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy.自然杀伤细胞功能障碍与癌症及利用 NK 细胞潜力进行癌症免疫治疗的新策略。
Mol Immunol. 2022 Apr;144:58-70. doi: 10.1016/j.molimm.2022.02.015. Epub 2022 Feb 21.
10
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.达雷妥尤单抗增强了在模拟肿瘤微环境条件的生化环境中针对 CD38+多发性骨髓瘤细胞系的同种异体反应性自然杀伤细胞的细胞毒性。
Cancer Immunol Immunother. 2018 Jun;67(6):861-872. doi: 10.1007/s00262-018-2140-1. Epub 2018 Mar 2.

引用本文的文献

1
Gut-Brain-Microbiome Axis in the Regulation of Cancer Immune Escape and Immunotherapy in Tumors.肠道-脑-微生物群轴在肿瘤免疫逃逸及免疫治疗调控中的作用
Research (Wash D C). 2025 Sep 11;8:0885. doi: 10.34133/research.0885. eCollection 2025.
2
New insights into mesenchymal stem cells in inflammatory subtypes of asthma.间充质干细胞在哮喘炎症亚型中的新见解。
Front Immunol. 2025 Aug 26;16:1649597. doi: 10.3389/fimmu.2025.1649597. eCollection 2025.
3
Emerging Strategies for Targeting Angiogenesis and the Tumor Microenvironment in Gastrointestinal Malignancies: A Comprehensive Review.

本文引用的文献

1
Dendritic Cell-Based Vaccines Recruit Neutrophils to the Local Draining Lymph Nodes to Prime Natural Killer Cell Responses.基于树突状细胞的疫苗将中性粒细胞募集到局部引流淋巴结,以启动自然杀伤细胞反应。
Cells. 2022 Dec 28;12(1):121. doi: 10.3390/cells12010121.
2
Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy.激活的 NK 细胞通过 NKG2D-NKG2DL 和 IFN-γ 重编程 MDSCs,以调节冷冻-热疗后抗肿瘤 T 细胞反应。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005769.
3
TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity.
靶向胃肠道恶性肿瘤血管生成和肿瘤微环境的新兴策略:综述
Pharmaceuticals (Basel). 2025 Aug 5;18(8):1160. doi: 10.3390/ph18081160.
4
The Role of Senescence, its Therapeutic Relevance and Clinical Implications in the Tumor Microenvironment.衰老在肿瘤微环境中的作用、其治疗相关性及临床意义
Theranostics. 2025 Jul 28;15(16):8675-8703. doi: 10.7150/thno.112633. eCollection 2025.
5
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses.分泌双特异性杀伤细胞衔接器的嵌合抗原受体T细胞重定向自然杀伤细胞特异性以增强抗肿瘤反应。
Nat Biomed Eng. 2025 Jul 14. doi: 10.1038/s41551-025-01450-4.
6
Novel strategy for tumor immunotherapy using FITC-folate bispecific adapter bridged CAR immune cell cocktails.使用异硫氰酸荧光素-叶酸双特异性衔接子桥接的嵌合抗原受体免疫细胞鸡尾酒进行肿瘤免疫治疗的新策略。
Bioact Mater. 2025 Jun 18;52:529-540. doi: 10.1016/j.bioactmat.2025.06.025. eCollection 2025 Oct.
7
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages.肝细胞癌中的淋巴细胞耗竭:疾病各阶段的动态演变
Front Immunol. 2025 Jun 6;16:1611365. doi: 10.3389/fimmu.2025.1611365. eCollection 2025.
8
NK cell activity in the tumor microenvironment.肿瘤微环境中的自然杀伤细胞活性。
Front Cell Dev Biol. 2025 May 30;13:1609479. doi: 10.3389/fcell.2025.1609479. eCollection 2025.
9
IPSC‑derived NK cells for immunotherapy and therapeutic perspective (Review).用于免疫治疗的诱导多能干细胞衍生自然杀伤细胞及其治疗前景(综述)
Mol Med Rep. 2025 Aug;32(2). doi: 10.3892/mmr.2025.13587. Epub 2025 Jun 6.
10
Toward precision oncology in LUAD: a prognostic model using single-cell sequencing and WGCNA based on a disulfidptosis relative gene signature.迈向肺腺癌的精准肿瘤学:一种基于二硫化物诱导细胞死亡相关基因特征,利用单细胞测序和加权基因共表达网络分析的预后模型。
Front Immunol. 2025 May 21;16:1581915. doi: 10.3389/fimmu.2025.1581915. eCollection 2025.
TEM8 三特异性杀伤剂结合肿瘤和肿瘤基质,特异性地激活自然杀伤细胞的抗肿瘤活性。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2022-004725.
4
γc cytokine-aided crosstalk between dendritic cells and natural killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating FOXP3 and programmed cell death protein 1.γc 细胞因子辅助树突状细胞和自然杀伤细胞之间的串扰,加上阿霉素,通过下调 FOXP3 和程序性细胞死亡蛋白 1,在实验性淋巴瘤中诱导愈合反应。
Cytotherapy. 2022 Dec;24(12):1232-1244. doi: 10.1016/j.jcyt.2022.07.012. Epub 2022 Aug 31.
5
Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects.自载纳米药物(SCND-SIS3):一种具有优异生物相容性和免疫增强作用的肺癌靶向治疗药物。
Biomaterials. 2022 Sep;288:121730. doi: 10.1016/j.biomaterials.2022.121730. Epub 2022 Aug 12.
6
Repurposing Vitamin C for Cancer Treatment: Focus on Targeting the Tumor Microenvironment.将维生素C重新用于癌症治疗:聚焦于靶向肿瘤微环境
Cancers (Basel). 2022 May 25;14(11):2608. doi: 10.3390/cancers14112608.
7
Tumor-Derived Lactate Creates a Favorable Niche for Tumor Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment.肿瘤衍生的乳酸为肿瘤创造了一个有利的微环境,为肿瘤提供能量来源并调节肿瘤微环境。
Front Cell Dev Biol. 2022 May 13;10:808859. doi: 10.3389/fcell.2022.808859. eCollection 2022.
8
A vaccine targeting resistant tumours by dual T cell plus NK cell attack.一种通过双重 T 细胞加自然杀伤细胞攻击来靶向耐药肿瘤的疫苗。
Nature. 2022 Jun;606(7916):992-998. doi: 10.1038/s41586-022-04772-4. Epub 2022 May 25.
9
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I tumors.STING 激动剂与 IL-2 超激动剂在 MHC I 缺陷和 MHC I 肿瘤的癌症免疫治疗中的协同作用。
Proc Natl Acad Sci U S A. 2022 May 31;119(22):e2200568119. doi: 10.1073/pnas.2200568119. Epub 2022 May 19.
10
The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone.微生物群通过促进肠道自然杀伤细胞和辅助性T1细胞归巢至骨骼来抑制黑色素瘤骨转移。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI157340.